319 related articles for article (PubMed ID: 11014564)
1. Genetic classification of combined hepatocellular-cholangiocarcinoma.
Fujii H; Zhu XG; Matsumoto T; Inagaki M; Tokusashi Y; Miyokawa N; Fukusato T; Uekusa T; Takagaki T; Kadowaki N; Shirai T
Hum Pathol; 2000 Sep; 31(9):1011-7. PubMed ID: 11014564
[TBL] [Abstract][Full Text] [Related]
2. Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity.
Fujii H; Yoshida M; Gong ZX; Matsumoto T; Hamano Y; Fukunaga M; Hruban RH; Gabrielson E; Shirai T
Cancer Res; 2000 Jan; 60(1):114-20. PubMed ID: 10646862
[TBL] [Abstract][Full Text] [Related]
3. Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas.
Cazals-Hatem D; Rebouissou S; Bioulac-Sage P; Bluteau O; Blanché H; Franco D; Monges G; Belghiti J; Sa Cunha A; Laurent-Puig P; Degott C; Zucman-Rossi J
J Hepatol; 2004 Aug; 41(2):292-8. PubMed ID: 15288479
[TBL] [Abstract][Full Text] [Related]
4. Pattern of chromosomal aberrations in primary liver cancers identified by comparative genomic hybridization.
Homayounfar K; Gunawan B; Cameron S; Haller F; Baumhoer D; Uecker S; Sander B; Ramadori G; Lorf T; Füzesi L
Hum Pathol; 2009 Jun; 40(6):834-42. PubMed ID: 19200581
[TBL] [Abstract][Full Text] [Related]
5. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast.
Fujii H; Szumel R; Marsh C; Zhou W; Gabrielson E
Cancer Res; 1996 Nov; 56(22):5260-5. PubMed ID: 8912866
[TBL] [Abstract][Full Text] [Related]
6. Allelotype analysis of intrahepatic cholangiocarcinoma.
Kang YK; Kim YI; Kim WH
Mod Pathol; 2000 Jun; 13(6):627-31. PubMed ID: 10874666
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive allelotyping of human intrahepatic cholangiocarcinoma.
Momoi H; Okabe H; Kamikawa T; Satoh S; Ikai I; Yamamoto M; Nakagawara A; Shimahara Y; Yamaoka Y; Fukumoto M
Clin Cancer Res; 2001 Sep; 7(9):2648-55. PubMed ID: 11555575
[TBL] [Abstract][Full Text] [Related]
8. Fractional allelic loss in non-end-stage cirrhosis: correlations with hepatocellular carcinoma development during follow-up.
Roncalli M; Bianchi P; Grimaldi GC; Ricci D; Laghi L; Maggioni M; Opocher E; Borzio M; Coggi G
Hepatology; 2000 Apr; 31(4):846-50. PubMed ID: 10733538
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity in clonal evolution with genetic progression and divergence in spindle cell carcinoma of the gallbladder.
Arakawa A; Fujii H; Matsumoto T; Hirai S; Suda K
Hum Pathol; 2004 Apr; 35(4):418-23. PubMed ID: 15116321
[TBL] [Abstract][Full Text] [Related]
10. Clonality analysis of multiple hepatocellular carcinomas by loss of heterozygosity pattern determined by chromosomes 16q and 13q.
Lin YW; Lee HS; Chen CH; Huang GT; Lee PH; Sheu JC
J Gastroenterol Hepatol; 2005 Apr; 20(4):536-46. PubMed ID: 15836701
[TBL] [Abstract][Full Text] [Related]
11. Copy number aberrations in combined hepatocellular carcinoma and cholangiocarcinoma.
You HL; Weng SW; Li SH; Wei YC; Sheu JJ; Chen CM; Huang WT
Exp Mol Pathol; 2012 Jun; 92(3):281-6. PubMed ID: 22366251
[TBL] [Abstract][Full Text] [Related]
12. Genotype stability and clonal evolution of hepatocellular carcinoma assessed by autopsy-based genome-wide microsatellite analysis.
Nishimura T; Nishida N; Komeda T; Fukuda Y; Nakao K
Cancer Genet Cytogenet; 2005 Sep; 161(2):164-9. PubMed ID: 16102588
[TBL] [Abstract][Full Text] [Related]
13. Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype.
Boige V; Laurent-Puig P; Fouchet P; Fléjou JF; Monges G; Bedossa P; Bioulac-Sage P; Capron F; Schmitz A; Olschwang S; Thomas G
Cancer Res; 1997 May; 57(10):1986-90. PubMed ID: 9157995
[TBL] [Abstract][Full Text] [Related]
14. Molecular diagnosis of primary liver cancer by microsatellite DNA analysis in the serum.
Chang YC; Ho CL; Chen HH; Chang TT; Lai WW; Dai YC; Lee WY; Chow NH
Br J Cancer; 2002 Dec; 87(12):1449-53. PubMed ID: 12454776
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive allelotyping of well-differentiated human hepatocellular carcinoma with semiquantitative determination of chromosomal gain or loss.
Nishimura T; Nishida N; Itoh T; Kuno M; Minata M; Komeda T; Fukuda Y; Ikai I; Yamaoka Y; Nakao K
Genes Chromosomes Cancer; 2002 Dec; 35(4):329-39. PubMed ID: 12378527
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular and cholangiolar carcinoma-derived cell lines reveal distinct sets of chromosomal imbalances.
Wilkens L; Hammer C; Glombitza S; Müller DE
Pathobiology; 2012; 79(3):115-26. PubMed ID: 22261732
[TBL] [Abstract][Full Text] [Related]
17. High-density allelotyping of chromosome 8p in hepatocellular carcinoma and clinicopathologic correlation.
Chan KL; Lee JM; Guan XY; Fan ST; Ng IO
Cancer; 2002 Jun; 94(12):3179-85. PubMed ID: 12115350
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic aberrations in primary and recurrent fibrolamellar hepatocellular carcinoma detected by comparative genomic hybridization.
Wilkens L; Bredt M; Flemming P; Kubicka S; Klempnauer J; Kreipe H
Am J Clin Pathol; 2000 Dec; 114(6):867-74. PubMed ID: 11338475
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide semiquantitative microsatellite analysis of human hepatocellular carcinoma: discrete mapping of smallest region of overlap of recurrent chromosomal gains and losses.
Nishimura T; Nishida N; Komeda T; Fukuda Y; Ikai I; Yamaoka Y; Nakao K
Cancer Genet Cytogenet; 2006 May; 167(1):57-65. PubMed ID: 16682288
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma.
Pang JZ; Qin LX; Ren N; Hei ZY; Ye QH; Jia WD; Sun BS; Lin GL; Liu DY; Liu YK; Tang ZY
Clin Cancer Res; 2007 Dec; 13(24):7363-9. PubMed ID: 18094418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
